UCSF Bay Area Center for AIDS Research (CFAR) coordinates a robust program focused on interdisciplinary research in HIV disease. @NIH funded, housed @UCSF
History in the Making
ZSFG and the Ongoing Fight Against HIV
Monday, December 1, 2025
3:30PM-5:00PM PST | Reception to follow
Carr Auditorium, Zuckerberg San Francisco General
(Zoom option available)
RSVP here: https://t.co/APt41VhGUI
Registration Now Open!
Annual Mentoring the Mentors Workshop for HIV Researchers
Aldea Center on Mount Sutro, San Francisco
Tuesday and Wednesday, January 13th and 14th, 2026
Registration deadline: October 31, 2025
https://t.co/gWbdFnkzTO
In EPITalk: Behind the Paper (@EPITalk_BTP) a podcast series from the Annals of Epidemiology journal, host (and journal Editor-in-Chief) Patrick Sullivan highlights UCSF-Bay Area CFAR’s Mentoring the Mentors Workshop during the conversation in their latest episode latest episode
Community Forum 5/11: Fostering Trust in Healthcare- Confronting Bias of Race, Gender and Sexual Orientation
Saturday, May 11, 2024
11AM-4PM
Register here: https://t.co/dBiVNaH5GW
April CFAR Seminar
Sara Gianella Weibel + CFAR Excellence Awards
Wednesday, April 10, 2024
9:35AM - 11:30AM PT
Carr Auditorium, ZSFG - Building 3 and Via Zoom
https://t.co/dRO4stUCGS
Ward 86 Job: Apply for this wonderful job opportunity in our Division at @UCSF . I am the Medical Director for Ward 86 HIV clinic here- wonderful place to work and with publicly-insured patients- we are innovative - apply for Associate Medical Director
https://t.co/exP8X2ACgW
DoxyPEP: Strategy by which men-who-have-with-men (MSM) & transgender women can take doxycycline as post-exposure prophylaxis after sex to prevent syphilis & chlamydia (gonorrhea needs vax). Astounding city-wide data from San Francisco -50% drop in both with DoxyPEP guidance.
Join us on 3/21 at 5PM EST via Zoom for the next #EmoryCFAR Synergy Seminar! Steve Grinspoon (@SteveGrinspoon) & Souheil Younes (@SouheilYounes) will present #HIV research updates for clinicians & virologists. RSVP for this cross-disciplinary session: https://t.co/iYS9ErMm72
LEN/CAB: Yes, we have been calling for a trial of lenacapavir/cabotegravir in low-and-middle-income countries because long-acting ART needed there & there is NNRTI resistance; we assembled this case series to help make this call- shows good efficacy
ENDEMIC: COVID will never be over so important to keep on developing biomedical advances to combat it. This is a middle-ground book to help quell the tension over the COVID response so rampant in the news/internet as we confront a non-eradicable virus.
https://t.co/JTJKXS7TvK
14th International Workshop on HIV & Aging HIV & Aging 2023
October 26-27,2023
Washington DC, United States
Format: Hybrid
Registration (Early Fee Deadline: 26 July 2023)
Abstract Submission (Deadline: 4 August 2023)
Website: https://t.co/PobmCthzQc